| 20.27 Data as of 3:59pm ET |  -0.09 / -0.44%Today’s Change | 10.26 Today|||52-Week Range 21.69 | +49.15% Year-to-Date |
| DexCom Stays at Neutral - Analyst Blog 2:03pm / Zacks.com |
| Previous close | 20.36 |
| Today’s open | 20.03 |
| Day’s range | 19.99 - 20.42 |
| Volume | 419,970 |
| Average volume (3 months) | 506,512 |
| Market cap | $1.4B |
| Dividend yield | -- |
| Earnings growth (last year) | -16.18% |
| Earnings growth (this year) | +28.13% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | +30.99% |
| P/E ratio | NM |
| Price/Sales | 9.35 |
| Price/Book | 18.38 |
| Today’s change | Today’s % change | |
|---|---|---|
| GMEDGlobus Medical Inc | +0.06 | +0.36% |
| PODDInsulet Corp | +0.52 | +1.81% |
| MASIMasimo Corp | +0.11 | +0.51% |
| IARTIntegra LifeSciences... | -0.16 | -0.42% |
| Next reporting date | August 6, 2013 |
| EPS forecast (this quarter) | -$0.16 |
| Annual revenue (last year) | $99.9M |
| Annual profit (last year) | -$54.5M |
| Net profit margin | -54.55% |
Sector Health Technology |
Industry Medical Specialties |
Chief Executive Officer & Director Terry H. Gregg |
President, Chief Operating Officer & Director Kevin Ronald Sayer, CPA |
Corporate headquarters San Diego, California |
.
